Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
QuintilesIMS
Julphar
Dow
Teva
UBS
Chinese Patent Office
Citi

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019204

« Back to Dashboard

NDA 019204 describes CARTROL, which is a drug marketed by Abbvie and is included in one NDA. Additional details are available on the CARTROL profile page.

The generic ingredient in CARTROL is carteolol hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the carteolol hydrochloride profile page.
Summary for 019204
Tradename:CARTROL
Applicant:Abbvie
Ingredient:carteolol hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019204

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2.5MG
Approval Date:Dec 28, 1988TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG
Approval Date:Dec 28, 1988TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG
Approval Date:Dec 28, 1988TE:RLD:No

Expired US Patents for NDA 019204

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-003 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-001 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-002 Dec 28, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Queensland Health
McKinsey
UBS
Boehringer Ingelheim
Federal Trade Commission
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.